abstract |
Described are compounds of formula I and intermediate compounds of formula II, in which R1 is a 5-membered nitrogen or oxygen monoheterocycle and the remaining substituents are defined herein. The compounds of formula II are used in the manufacture of medicaments for treating diseases related to a coronary electrical disorder in a mammal. |